(Times of Israel) David Shamah - Scientists at the Weizmann Institute may have found the cure for prostate cancer if caught in its early stages - via a drug injected into cancerous cells treated with infrared laser illumination. Using a therapy lasting 90 minutes, the drug, called Tookad Soluble, targets and destroys cancerous prostate cells, studies show. The drug is being marketed by Steba Biotech, an Israeli biotech start-up, and was developed in the lab of Weizmann Institute professors Yoram Salomon and Avigdor Scherz. In a Phase III clinical trial of 80 patients from Latin America, over 80% of the study's subjects remained cancer-free two years after treatment and a similar study in Europe showed similar results.
2016-04-08 00:00:00Full ArticleBACK Visit the Daily Alert Archive